ELOXX PHARMACEUTICALS INC's ticker is and the CUSIP is 29014R202. A total of 19 filers reported holding ELOXX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,169 | – | 10,638 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 54,075 | $260,101 | 0.08% |
| AMERICAN FINANCIAL GROUP INC | 37,000 | $178 | 0.06% |
| ARMISTICE CAPITAL, LLC | 275,000 | $1,322,750 | 0.02% |
| Atom Investors LP | 10,638 | $51,169 | 0.01% |
| Altshuler Shaham Ltd | 25,123 | $120,842 | 0.00% |
| MENORA MIVTACHIM HOLDINGS LTD. | 52,355 | $251,828 | 0.00% |
| Clal Insurance Enterprises Holdings Ltd | 13,526 | $65 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,172 | $5,637 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 19,588 | $93,264 | 0.00% |